Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term liver toxicity of thiopurines in inflammatory bowel disease
NL-OMON22783Not yet recruiting
- Sponsor
- Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of azathioprine, mercaptopurine and tioguanine in Crohn's disease, autoimmune colitis and inflammatory bowel disease (IBD) (3 cohorts), sponsored by Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands. Planned start Jan 2009; status: not yet recruiting.
02
Drugs
azathioprinemercaptopurinetioguanine
03
Conditions
Crohn's diseaseautoimmune colitisinflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NL-OMON22783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22783.